VDR

Two people can have the same vitamin D level in their blood and still get very different benefits from it. Part of the reason is built into your DNA, in the gene that tells your cells how to make and use the vitamin D receptor.

This test reads common variants in the VDR (vitamin D receptor) gene. It does not tell you how much vitamin D you have. It offers an early, exploratory window into how your body may handle vitamin D for bone, immune, metabolic, and inflammatory pathways.

What VDR Actually Is

VDR (vitamin D receptor) is a protein that sits inside almost every cell type in the body, from gut lining cells to immune cells, muscle, brain, liver, and bone. When the active form of vitamin D binds to it, VDR pairs up with another protein, attaches to specific spots on your DNA, and turns hundreds of genes on or off.

Common single letter changes (called SNPs, short for single nucleotide polymorphisms) in the VDR gene, with names like FokI, BsmI, ApaI, and TaqI, can change how much VDR protein you make or how well it works. These variants do not give you a disease on their own. They subtly shift how your body responds to vitamin D over a lifetime.

Why VDR Genetics Matter for Vitamin D Response

Even with the same supplement dose, people raise their vitamin D levels differently. A pooled analysis of supplementation studies found that people carrying certain TaqI and FokI variants had a better blood response to vitamin D supplementation than those without these variants. If your levels barely move on a standard supplement dose, your VDR genetics may be part of the explanation.

A large analysis of older adults found that common VDR variants appeared to change the link between low vitamin D and major health outcomes, including death from any cause. The number on a vitamin D blood test may not mean the same thing in every person, and VDR variants help explain why.

Heart and Metabolic Risk

VDR variants have been studied across heart and metabolic disease. In a UK Biobank style study of about 396,000 adults, vitamin D level was linked to risk of having multiple heart and metabolic diseases at once, and VDR variants changed the strength of that link. In about 14,600 adults with type 2 diabetes, those with higher vitamin D levels had lower risk of eye, nerve, and kidney complications, and certain VDR variants modified the size of that protection.

A trial sequential meta-analysis of coronary artery disease found that one VDR variant (rs1544410) was linked to higher coronary artery disease risk, while another (rs7975232) was linked to lower risk. A meta-analysis of high blood pressure found that the BsmI variant was associated with lower risk of essential hypertension. A small Polish study reported that the AA genotype of one VDR variant appeared protective against cardiovascular disease, while the TT genotype tracked with more hypertension and obesity.

Liver Disease

VDR genetics have been linked to fatty liver disease severity. In 229 adults with biopsy proven nonalcoholic fatty liver disease, low vitamin D and one VDR variant (rs1544410 CC genotype) were each independently associated with more advanced liver scarring. In a Chinese case control study of more than 3,000 adults, two VDR variants combined with exercise slightly improved early prediction of nonalcoholic fatty liver disease.

Gut Inflammation and Crohn's Disease

VDR helps keep the gut lining tight and the immune system steady. In 103 people with Crohn's disease, a VDR variant linked to lower VDR protein in immune cells was tied to higher inflammation signals, a more aggressive (penetrating) form of disease, and a higher chance of needing surgery. A study of 176 adults with Crohn's disease found that the ApaI variant influenced disease behavior, progression, and response to treatment, with the aa genotype appearing more protective.

Cancer Associations

VDR variants have been studied across many cancers, with mixed results. A meta-analysis of 39 studies found that the FokI variant was linked to higher breast cancer risk, while other variants showed no clear link. A separate umbrella review found that BsmI, Cdx-2, and Poly (A) variants were not strongly tied to breast cancer risk in the general population. Findings depend heavily on ethnicity, and the size of any effect is small.

In a meta-analysis of colorectal cancer, the BsmI variant was linked to higher colon cancer risk but not rectal cancer. A study of 537 adults found that VDR variants were tied to colorectal cancer risk and progression, with certain mutant genotypes linked to lower overall survival. A meta-analysis of melanoma data found the FokI variant linked to higher melanoma risk and BsmI possibly protective.

Brain and Nerve Health

VDR is active in many brain regions, including areas involved in memory and movement. A case control study of 200 adults with Parkinson's disease in Bangladesh found that the ApaI and FokI variants were significantly tied to higher Parkinson's risk. A separate study of 392 patients found that VDR variants were linked to Parkinson's susceptibility and to certain side effects of dopamine based treatment.

Why This Is Not a Pass or Fail Result

VDR variants do not work like a single switch. Two findings can look like they contradict each other (one variant raising risk in one disease while lowering it in another). The reason: VDR controls hundreds of genes, and different organs use VDR in different ways. Your genotype is one of many inputs into how your body uses vitamin D, alongside your actual vitamin D level, sun exposure, body weight, gut health, kidney function, and many other genes.

This is also a Tier 3, exploratory marker. There are no agreed clinical cutpoints from major guideline bodies, no recommendation to use VDR genotyping as a routine screen, and no clinical trial showing that changing your behavior based on VDR genotype improves outcomes. Your result is information, not a verdict.

Tracking Over Time

Your VDR genotype is set at birth and does not change. You do not need to retest VDR itself. What is worth tracking is everything VDR sits on top of: your blood vitamin D level (25-hydroxyvitamin D), how your body responds to a supplement dose, and the downstream markers that vitamin D signaling influences.

Get a baseline vitamin D level, start any supplement plan your doctor recommends, then retest vitamin D in 3 to 6 months. If you carry VDR variants linked to a weaker response (such as certain FokI or TaqI genotypes), your blood vitamin D number may take longer to climb or may need a higher dose. At least annual vitamin D monitoring is reasonable for anyone actively managing the pathway.

Decision Pathway

If your VDR result shows variants linked to weaker vitamin D response or higher risk for a specific condition, that result is most useful when paired with the rest of your panel. Combine it with a 25-hydroxyvitamin D level to see whether your current status is adequate. Combine it with markers of inflammation, metabolic health, and bone health to understand which pathways may be most affected for you.

If you also have a family history of osteoporosis, autoimmune disease, fatty liver, Crohn's disease, or early heart disease, a VDR result that aligns with risk for those conditions is worth bringing to your primary care doctor or a relevant specialist. For chronic vitamin D deficiency that does not respond to supplementation, an endocrinologist can investigate whether VDR variation, gut absorption, or other vitamin D pathway genes are at play.

When Results Can Be Misleading

A genetic test is one of the most stable results you can get. Your genotype does not change with food, exercise, time of day, or recent illness. The main risks of misreading a VDR result are:

• Treating a single variant as destiny: carrying a risk linked variant slightly shifts probabilities. It does not predict that you will or will not develop a disease.
• Ignoring ethnicity: the effect of specific VDR variants on cancer and other risks varies meaningfully by ancestry, and most studies have been done in specific populations.
• Confusing this with a vitamin D blood test: VDR genetics tells you about machinery. A 25-hydroxyvitamin D blood test tells you about fuel. You usually need both to act on the pathway.